mefloquine has been researched along with Neglected Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avery, VM; Sykes, ML | 1 |
| Kameda, K | 1 |
1 review(s) available for mefloquine and Neglected Diseases
| Article | Year |
|---|---|
Approaches to protozoan drug discovery: phenotypic screening.
Topics: Drug Discovery; Humans; Molecular Structure; Neglected Diseases; Phenotype; Plasmodium falciparum; Protozoan Infections; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosoma cruzi | 2013 |
1 other study(ies) available for mefloquine and Neglected Diseases
| Article | Year |
|---|---|
Needs-driven versus market-driven pharmaceutical innovation: the consortium for the development of a new medicine against malaria in Brazil.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Brazil; Drug Combinations; Drug Discovery; Drug Industry; Global Health; Health Care Sector; Health Services Needs and Demand; Humans; Internationality; Inventions; Malaria; Mefloquine; Neglected Diseases; Patents as Topic; Social Justice | 2014 |